Advances in virus-like particle vaccines for filoviruses.
about
Pre-symptomatic diagnosis and treatment of filovirus diseasesShedding light on filovirus infection with high-content imagingEbola virus vaccines: an overview of current approachesParticulate delivery systems for vaccination against bioterrorism agents and emerging infectious pathogensDevelopment of RNA Aptamers Targeting Ebola Virus VP35Ebola: facing a new transboundary animal disease?Virus like particle-based vaccines against emerging infectious disease viruses.Therapeutics for filovirus infection: traditional approaches and progress towards in silico drug design.Homologous and heterologous protection of nonhuman primates by Ebola and Sudan virus-like particles.The role of antigen-presenting cells in filoviral hemorrhagic fever: gaps in current knowledge.Forty-five years of Marburg virus research.Ebola virus-like particles stimulate type I interferons and proinflammatory cytokine expression through the toll-like receptor and interferon signaling pathways.Modeling pre-existing immunity to adenovirus in rodents: immunological requirements for successful development of a recombinant adenovirus serotype 5-based ebola vaccine.Bioengineering virus-like particles as vaccines.Animal models for ebolavirus countermeasures discovery: what defines a useful model?Recombinant Modified Vaccinia Virus Ankara Generating Ebola Virus-Like Particles.Ebola virus vaccines - reality or fiction?Hemorrhagic Fever Virus Budding Studies.Recombinant vaccines of a CD4+ T-cell epitope promote efficient control of Paracoccidioides brasiliensis burden by restraining primary organ infection.Marburg virus-like particles by co-expression of glycoprotein and matrix protein in insect cells induces immune responses in miceEbola Virus Neutralizing Antibodies Detectable in Survivors of theYambuku, Zaire Outbreak 40 Years after Infection.Alphavirus Replicon DNA Vectors Expressing Ebola GP and VP40 Antigens Induce Humoral and Cellular Immune Responses in Mice.Distinct Immunogenicity and Efficacy of Poxvirus-based Vaccine Candidates against Ebola Virus expressing GP and VP40 Proteins.Animal Models of Ebolavirus Infection
P2860
Q26823831-CF78149E-8D93-4412-9165-2C981B3B631DQ26863739-1A4B4EFB-E5CB-439B-BAEA-678BB4D9AEEBQ26999232-67E6F11D-B437-437F-8217-607EF4571826Q27011190-BEFF93C7-1533-489B-AC68-A54B173AEAD5Q27680060-3677164F-01CE-4B09-B35E-AC14EA23B319Q30222969-D6B69C35-EE8D-440D-939B-028C6B15E0D3Q30249025-692F84CF-858A-477C-96BE-2F1FB168200DQ34371001-174D1CB1-27E5-4F14-8E19-39CF083C7435Q35202880-35BA685F-2DE5-41F9-8D70-DC5651F7890EQ35823426-A6718753-5FE6-48FF-B06D-581FF9598838Q36395831-C4D0DAD2-D7BC-4195-B217-F8166E264309Q37584926-078AF5E3-6310-4B09-A70D-1DD235A58A36Q37627897-0625904F-A57F-4654-8BEF-BAEAA1428932Q38172045-5E669382-FB72-4AE2-A977-31717608F52AQ38500788-439962C8-93C0-4553-A255-07099EB60F0AQ38741327-A80402BA-E527-4915-A5E8-1B0A8C3A9F7DQ38881265-A9E4A6BB-F2DA-439C-8566-F4C4A90AFF95Q41922409-BFD266DC-B3E9-4BA1-B68B-792A44F282F1Q41932144-12C5AA06-01E8-4359-BBA4-F90860103363Q42628113-BDDFE622-F5B5-45D2-B724-8D84459AF1BCQ46653237-D9EE07DC-28E9-4A11-A3CA-E78E6425CA4AQ47548508-50EFF25B-FB6B-4A37-8204-04367A2AA3F4Q51784219-31727235-341D-474B-A4CE-85408B56F237Q56541916-733F052F-A2C6-46EB-9260-034361AEE1D3
P2860
Advances in virus-like particle vaccines for filoviruses.
description
2011 nî lūn-bûn
@nan
2011 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年学术文章
@wuu
2011年学术文章
@zh-cn
2011年学术文章
@zh-hans
2011年学术文章
@zh-my
2011年学术文章
@zh-sg
2011年學術文章
@yue
name
Advances in virus-like particle vaccines for filoviruses.
@ast
Advances in virus-like particle vaccines for filoviruses.
@en
type
label
Advances in virus-like particle vaccines for filoviruses.
@ast
Advances in virus-like particle vaccines for filoviruses.
@en
prefLabel
Advances in virus-like particle vaccines for filoviruses.
@ast
Advances in virus-like particle vaccines for filoviruses.
@en
P2860
P356
P1476
Advances in virus-like particle vaccines for filoviruses.
@en
P2093
Kelly L Warfield
M Javad Aman
P2860
P304
P356
10.1093/INFDIS/JIR346
P407
P478
204 Suppl 3
P577
2011-11-01T00:00:00Z